Physician profile
John George
NPI 1023540382
$1,493.80
in general payments reported to CMS, 2019-2025
9 companies · $658 in 2025
The $658 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2022: $269 · 2023: $192 · 2024: $29.92 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $405.44 | 2022-2023 | Endoflip |
| Amgen INC. | $310.41 | 2025 | Uplizna |
| Abbvie INC. | $245.88 | 2023-2025 | |
| Viiv Healthcare Company | $125.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $122.10 | 2019 | |
| Celltrion USA INC. | $112.00 | 2025 | Zymfentra |
| Emd Serono, INC. | $97.96 | 2019 | |
| Phathom Pharmaceuticals, INC. | $45.09 | 2025 | Voquezna |
| Abiomed | $29.92 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.